Bisoprolol 5 mg US Equivalent
Bisoprolol 5 mg is directly equivalent to bisoprolol fumarate 5 mg in the US, as it is the same medication marketed under the same dosage. 1
Bisoprolol Overview
Bisoprolol is a cardioselective beta-blocker available in the US under the same dosage strength as in other countries:
- Bisoprolol is FDA-approved in the US in 2.5 mg, 5 mg, and 10 mg tablet strengths 2
- It is classified as a cardioselective beta-blocker (primarily blocks β1 receptors) 1
- The usual dosage range is 2.5-10 mg once daily 1
- It has a long half-life of 9-12 hours, allowing for once-daily dosing 3
Clinical Applications
Bisoprolol is commonly used for:
- Hypertension management (2.5-10 mg once daily) 1
- Heart failure with reduced ejection fraction (HFrEF) (target dose 10 mg once daily) 1
- Rate control in atrial fibrillation (2.5-10 mg once daily) 1
Pharmacokinetic Properties
- High absolute bioavailability (90%) due to nearly complete absorption (>90%) and small first-pass effect (10%) 3
- Long plasma elimination half-life (10-11 hours) allowing once-daily dosing 3
- Balanced clearance (equieffective hepatic and renal clearance) making it less sensitive to organ dysfunction 3
- Low plasma protein binding (30%), reducing risk of drug interactions 3
- No significant food interactions - can be taken with or without food 3
Comparative Efficacy
When considering equivalent doses of other beta-blockers for similar clinical effects:
- Bisoprolol 5 mg ≈ Metoprolol succinate 50-100 mg 1
- Bisoprolol 5 mg ≈ Atenolol 50 mg 1
- Bisoprolol 5 mg ≈ Carvedilol 12.5 mg twice daily 1
Clinical Considerations
- Lower doses (2.5 mg) may be sufficient for blood pressure control in some patients 4
- Bisoprolol has been shown to reduce left ventricular mass in hypertensive patients with left ventricular hypertrophy 5
- It has minimal effects on lipid profiles compared to other beta-blockers, especially at lower doses 4
- Bisoprolol should be initiated at lower doses (1.25-2.5 mg) in heart failure patients and titrated gradually 1
Common Side Effects
- Bradycardia, fatigue, dizziness, and headache are the most commonly reported adverse effects 2
- Incidence of adverse events with 5 mg dosing is comparable to placebo in clinical trials 2, 6
- Less likely to cause bronchospasm than non-selective beta-blockers, but still should be used with caution in patients with reactive airway disease 2, 7
Conclusion
For a patient currently taking bisoprolol 5 mg, the direct US equivalent is bisoprolol fumarate 5 mg. No dose adjustment or medication change is necessary when transitioning between countries, as the medication and dosing are identical in the US market.